Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca(2+) Handling and NRF2 Activation

Specialized proresolving mediators and, in particular, 5(S), (6)R, 7-trihydroxyheptanoic acid methyl ester (BML-111) emerge as new therapeutic tools to prevent cardiac dysfunction and deleterious cardiac damage associated with myocarditis progression. The cardioprotective role of BML-111 is mainly c...

Descripción completa

Detalles Bibliográficos
Autores principales: Val-Blasco, Almudena, Prieto, Patricia, Jaén, Rafael Iñigo, Gil-Fernández, Marta, Pajares, Marta, Domenech, Nieves, Terrón, Verónica, Tamayo, María, Jorge, Inmaculada, Vázquez, Jesús, Bueno-Sen, Andrea, Vallejo-Cremades, María Teresa, Pombo-Otero, Jorge, Sanchez-García, Sergio, Ruiz-Hurtado, Gema, Gómez, Ana María, Zaragoza, Carlos, Crespo-Leiro, María Generosa, López-Collazo, Eduardo, Cuadrado, Antonio, Delgado, Carmen, Boscá, Lisardo, Fernández-Velasco, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Preclinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270570/
https://www.ncbi.nlm.nih.gov/pubmed/35818504
http://dx.doi.org/10.1016/j.jacbts.2022.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270570/
https://www.ncbi.nlm.nih.gov/pubmed/35818504
http://dx.doi.org/10.1016/j.jacbts.2022.01.009

Ejemplares similares